Intercept Pharmaceuticals Inc Доход
Что обозначает Доход в Intercept Pharmaceuticals Inc?
Доход Intercept Pharmaceuticals Inc является $277.047M
Какое определение для Доход?
Доход - это прибыль, которую бизнес получает от обычной деловой деятельности, обычно от продажи товаров и предоставления услуг клиентам.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Доход компаний в Health Care сектор на NASDAQ по сравнению с Intercept Pharmaceuticals Inc
Что делает Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Компании с доход похож на Intercept Pharmaceuticals Inc
- First Shanghai Investments имеет Доход из HKD$276.400M
- Xinhua News Media имеет Доход из HKD$276.486M
- Aedifica SA имеет Доход из €276.566M
- Goosehead Insurance Inc имеет Доход из $276.592M
- GlobalData Plc имеет Доход из £276.800M
- Muehlhan AG имеет Доход из €277.029M
- Intercept Pharmaceuticals Inc имеет Доход из $277.047M
- First Bancshares Inc Miss имеет Доход из $277.272M
- EXFO имеет Доход из $277.485M
- Visiativ SA имеет Доход из €277.500M
- Pharming N.V имеет Доход из $277.600M
- Esperion Therapeutics имеет Доход из $277.788M
- Bang Overseas имеет Доход из ₨278.270M